Nursing measures to support the needs of haematological cancer survivors post-treatment: a literature review

Advances in cancer treatment have resulted in a growing population of people who are alive and in remission from their cancer (cancer survivors) following treatment (Bower and Waxman, 2015). The increase in survival rate relates to early diagnosis and improvements in the types of treatment that are available (Jefford et al, 2008).

Haematological malignancies are blood-borne cancers beginning in the blood-forming tissues, that can range from slow-developing and chronic, to fast-growing and acute diseases. It is estimated that around 250 000 people are living with a haematological cancer, making it the fifth most common form of cancer in the UK (Bloodwise, 2014). Depending on the type of cancer and its growth rate, as well as the physical health of the patient at presentation, treatment options vary. Individuals with slow-growing cancers are likely to be actively monitored, with non-intensive chemotherapy treatment initiated in the presence of changes (Bloodwise, 2016). Where disease is advanced at presentation and diagnosis, or in the case of disease progression, individuals may receive supportive or palliative care, in order to manage the physical symptoms and provide emotional support (Bloodwise, 2016).